FI834700A0 - Dna-sekvenser, deras framstaellning, dessa sekvenser innehaollande plasmider och deras anvaendning syntes av eukaryotiska genprodukter i prokaryoten - Google Patents
Dna-sekvenser, deras framstaellning, dessa sekvenser innehaollande plasmider och deras anvaendning syntes av eukaryotiska genprodukter i prokaryotenInfo
- Publication number
- FI834700A0 FI834700A0 FI834700A FI834700A FI834700A0 FI 834700 A0 FI834700 A0 FI 834700A0 FI 834700 A FI834700 A FI 834700A FI 834700 A FI834700 A FI 834700A FI 834700 A0 FI834700 A0 FI 834700A0
- Authority
- FI
- Finland
- Prior art keywords
- sequence
- plasmider
- framstering
- eucarotic
- derasional
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 239000013612 plasmid Substances 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 102000014150 Interferons Human genes 0.000 abstract 1
- 108010050904 Interferons Proteins 0.000 abstract 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 1
- 241000607715 Serratia marcescens Species 0.000 abstract 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 1
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 239000013613 expression plasmid Substances 0.000 abstract 1
- 229940079322 interferon Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- C12N15/68—Stabilisation of the vector
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823247922 DE3247922A1 (de) | 1982-12-24 | 1982-12-24 | Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten |
| DE3247922 | 1982-12-24 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI834700A0 true FI834700A0 (fi) | 1983-12-21 |
| FI834700L FI834700L (fi) | 1984-06-25 |
| FI86991B FI86991B (fi) | 1992-07-31 |
| FI86991C FI86991C (fi) | 1992-11-10 |
Family
ID=6181687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI834700A FI86991C (fi) | 1982-12-24 | 1983-12-21 | Rekombinant-dna-sekvenser, deras framstaellning och dessa sekvenser innehaollande plasmider |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0115613B1 (fi) |
| JP (2) | JPH088868B2 (fi) |
| KR (1) | KR930005455B1 (fi) |
| AT (1) | ATE62018T1 (fi) |
| AU (1) | AU579991B2 (fi) |
| DD (1) | DD216043A5 (fi) |
| DE (2) | DE3247922A1 (fi) |
| DK (1) | DK576983A (fi) |
| ES (4) | ES528350A0 (fi) |
| FI (1) | FI86991C (fi) |
| GR (1) | GR78766B (fi) |
| HU (1) | HU202277B (fi) |
| IL (1) | IL70523A (fi) |
| MX (1) | MX9202878A (fi) |
| NO (1) | NO173742C (fi) |
| NZ (1) | NZ206700A (fi) |
| SU (2) | SU1366064A3 (fi) |
| UA (1) | UA8035A1 (fi) |
| ZA (1) | ZA839519B (fi) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3584198D1 (de) * | 1984-08-01 | 1991-10-31 | Boehringer Ingelheim Int | Neue genetische sequenzen, die durch sie codierten interferon-peptide vom typ i und diese sie produzierende organismen. |
| US6291662B1 (en) | 1984-12-05 | 2001-09-18 | Amgen Inc. | Recombinant methods for production of serine protease inhibitors and DNA sequences |
| WO1986003519A1 (en) * | 1984-12-06 | 1986-06-19 | Synergen Biologicals, Inc. | Recombinant methods for production of serine protease inhibitors and dna sequences useful for same |
| FI90990C (fi) * | 1984-12-18 | 1994-04-25 | Boehringer Ingelheim Int | Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi |
| DK156072C (da) * | 1985-04-03 | 1989-11-06 | Nordisk Gentofte | Syntetisk dna-sekvens indeholdende et ribosombindingssted |
| DK151585D0 (da) * | 1985-04-03 | 1985-04-03 | Nordisk Gentofte | Dna-sekvens |
| DE3514113A1 (de) * | 1985-04-19 | 1986-10-23 | Hoechst Ag, 6230 Frankfurt | Veraenderung der dna-sequenz zwischen shine-dalgarno-sequenz und startcodon des trp-operons zur steigerung der proteinexpression |
| US4874703A (en) * | 1985-08-26 | 1989-10-17 | Eli Lilly And Company | Expression vectors for use in E. coli |
| DE3607835A1 (de) * | 1986-03-10 | 1987-09-24 | Boehringer Ingelheim Int | Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung |
| DE3642096A1 (de) * | 1986-12-10 | 1988-06-16 | Boehringer Ingelheim Int | Pferde-(gamma)-interferon |
| GB8813032D0 (en) * | 1988-06-02 | 1988-07-06 | Boehringer Ingelheim Int | Antiviral pharmaceutical composition |
| WO1990005186A1 (en) * | 1988-11-04 | 1990-05-17 | The Upjohn Company | Somatotropin expression using a serratia promoter |
| IL108584A (en) * | 1994-02-07 | 2008-03-20 | Yeda Res & Dev | Cloning of interferon -alpha/beta binding protein |
| EP0626448A3 (de) * | 1993-05-26 | 1998-01-14 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Verfahren zur Herstellung und Reinigung von alpha-Interferon |
| US5531880A (en) * | 1994-09-13 | 1996-07-02 | Microelectronics And Computer Technology Corporation | Method for producing thin, uniform powder phosphor for display screens |
| FR2724665B1 (fr) * | 1994-09-16 | 1996-12-20 | Rhone Poulenc Rorer Sa | Procede de production de proteines recombinantes, plasmides et cellules modifiees |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA811368B (en) * | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
| DE3176011D1 (en) * | 1980-06-12 | 1987-04-23 | Japan Found Cancer | Plasmid |
| ZA814375B (en) * | 1980-07-01 | 1982-07-28 | Hoffmann La Roche | Interferons and process for their preparation |
| IE52755B1 (en) * | 1980-08-26 | 1988-02-17 | Univ California | Bovine pre-growth and growth hormone |
| DE3280127D1 (de) * | 1981-03-27 | 1990-04-12 | Ici Plc | Genetisch modifizierte mikroorganismen. |
| DE3220116A1 (de) * | 1982-05-28 | 1983-12-01 | Dr. Karl Thomae Gmbh, 7950 Biberach | Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung |
| DE3247923A1 (de) * | 1982-12-24 | 1984-06-28 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue oligonucleotide und verfahren zu ihrer herstellung |
-
1982
- 1982-12-24 DE DE19823247922 patent/DE3247922A1/de not_active Withdrawn
-
1983
- 1983-12-02 GR GR73142A patent/GR78766B/el unknown
- 1983-12-14 DK DK576983A patent/DK576983A/da not_active Application Discontinuation
- 1983-12-20 EP EP83112812A patent/EP0115613B1/de not_active Expired - Lifetime
- 1983-12-20 AT AT83112812T patent/ATE62018T1/de not_active IP Right Cessation
- 1983-12-20 DE DE8383112812T patent/DE3382233D1/de not_active Expired - Fee Related
- 1983-12-21 FI FI834700A patent/FI86991C/fi not_active IP Right Cessation
- 1983-12-22 IL IL70523A patent/IL70523A/xx not_active IP Right Cessation
- 1983-12-22 DD DD83258476A patent/DD216043A5/de unknown
- 1983-12-22 ZA ZA839519A patent/ZA839519B/xx unknown
- 1983-12-22 HU HU834419A patent/HU202277B/hu not_active IP Right Cessation
- 1983-12-22 NZ NZ206700A patent/NZ206700A/en unknown
- 1983-12-23 NO NO834792A patent/NO173742C/no unknown
- 1983-12-23 KR KR1019830006147A patent/KR930005455B1/ko not_active Expired - Fee Related
- 1983-12-23 ES ES528350A patent/ES528350A0/es active Granted
- 1983-12-23 SU SU833681952A patent/SU1366064A3/ru active
- 1983-12-23 UA UA3681952A patent/UA8035A1/uk unknown
- 1983-12-23 JP JP58243626A patent/JPH088868B2/ja not_active Expired - Lifetime
- 1983-12-23 AU AU22832/83A patent/AU579991B2/en not_active Ceased
-
1984
- 1984-06-07 ES ES533197A patent/ES533197A0/es active Granted
- 1984-06-07 ES ES533213A patent/ES8506090A1/es not_active Expired
- 1984-06-07 ES ES533214A patent/ES533214A0/es active Granted
-
1985
- 1985-08-02 SU SU853935004A patent/SU1417800A3/ru active
-
1992
- 1992-01-23 JP JP4009692A patent/JP2637328B2/ja not_active Expired - Lifetime
- 1992-06-15 MX MX9202878A patent/MX9202878A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI834700A0 (fi) | Dna-sekvenser, deras framstaellning, dessa sekvenser innehaollande plasmider och deras anvaendning syntes av eukaryotiska genprodukter i prokaryoten | |
| Taniguchi et al. | Expression of the human fibroblast interferon gene in Escherichia coli. | |
| DK305885A (da) | Tumornecrosefaktor og derivater og mutantformer deraf, frem. til frems. deraf, frem. til isolering deraf fra en blanding med andre proteiner,praeparater deraf, dna som koder derfor, dna'en inkorporeret i en replicerbar vektor og celle transformeret dermed | |
| JPS5777654A (en) | Nonglycosylated interferon | |
| SE8703539L (sv) | Artificiell gen och proteinprodukt | |
| ES8603574A1 (es) | "procedimiento de tecnologia genetica para preparar secuen- cias parciales del gamma-interferon de humano". | |
| IL81018A (en) | Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process | |
| ZA957750B (en) | Process for producing recombinant proteins plasmids and modified cells | |
| DK0652903T3 (da) | Nyt humant rekombinant gammainterferon | |
| EP0072541A3 (en) | Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them | |
| FR2556365B1 (fr) | Vecteurs de clonage et d'expression de l'interferon-g, bacteries transformees et procede de preparation de l'interferon-g | |
| DE3585695D1 (de) | Expressionsplasmide die vollstaendige cdna-sequenz von kalbsprochymosin enthaltend. | |
| FI901219A0 (fi) | Artificiell gen, som kodar foer autentiskt maenskligt serumalbumin, dess anvaendning och foerfarande foer framstaellning daerav. | |
| SU1515698A1 (ru) | Рекомбинантная плазмидная днк, кодирующая синтез hbs ag вируса гепатита b, и штамм вируса осповакцины - продуцент hbs ag вируса гепатита b |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH |